Yes, ethambutol is a chelator that produces a mitochondrial optic neuropathy by consuming the iron, zinc and copper that the mitochondrial ribosomes use. It's usually the zinc and copper that's hardest to supplement which is why Emily Chu included them on the AREDS formula. We proved the rescue in a rat RGC model of the disease.
Ethambutol-induced vacuolar changes and neuronal loss in rat retinal cell culture: mediation by endogenous zinc
Best,
Alfredo
Original Message:
Sent: 5/15/2026 1:44:00 PM
From: Larry Frohman
Subject: RE: UPFRONT
I think she was one of two cases (it has been >1 decade) where we talked with Alfredo, who suggested double dose of AREDS to supplement copper and zinc.
Original Message:
Sent: 5/15/2026 1:25:00 PM
From: Scott Forman
Subject: RE: UPFRONT
And how did you treat this "beautifully evolving" visual loss??!
ScottForman, MD
Original Message:
Sent: 5/15/2026 11:59:00 AM
From: Alfredo Sadun
Subject: RE: UPFRONT
Hi Neringa,
How do you know it's chiasmatic? Bilateral central scotomas with some preferential temporal loss in ethambutol toxicity has an explanation other than a chiasmatic location. And check how pure the respect for the vertical really is.
Ethambutol toxicity affects the smallest PMB fibers. Those that course nasally to the disc are smaller than those that arc around the fovea. If the former are more adversely involved, you will get more temporal and less nasal field loss.
Alfredo
Original Message:
Sent: 5/15/2026 11:51:00 AM
From: Neringa Jurkute
Subject: RE: UPFRONT
Indeed.
I have a case of chismitis secondary to ethambutol toxicity and beautifully evolving RGC loss after acute onset.
BW
Neri
Original Message:
Sent: 5/15/2026 11:07:00 AM
From: Scott Forman
Subject: RE: UPFRONT
Yes my follow up is in a few weeks which may be too early. Making it interactive is easy as this is a good example of how Ethambutol toxicity can be chiasmal in location and therefore central 10-2 is important.
Original Message:
Sent: 5/15/2026 9:33:00 AM
From: Larry Frohman
Subject: RE: UPFRONT
Maybe after you have outcomes? Would you be able to make it interactive? Our goal is to show how we can make a difference in a patient's care
Original Message:
Sent: 5/15/2026 8:19:00 AM
From: Scott Forman
Subject: RE: UPFRONT
Larry,
I forgot about this. I have an excellent case of chiasma visual loss from a man who developed TB abscesses in the spine from BCG bladder treatments for Bladder Cancer and was placed on extremely high doses of Ethambutol as part of his triple antibiotic regimen. I am treating him now.
Original Message:
Sent: 5/15/2026 7:14:00 AM
From: Larry Frohman
Subject: UPFRONT
Just a reminder- a few of you have started cases, please do complete them and send to me, as we strive to publish at least two cases per quarter. And if you have an idea for an UPFRONT Case, just email me a few sentences describing it so we can make sure it seems appropriate for the goals of the series (to interest med students and especially neurology and ophthalmology residents in what we do)>